BrdU labelling involves administering BrdU to cells or organisms, either through injection or cell culture. Once BrdU is incorporated into the DNA, the tissue or cells can be harvested and processed for detection. The detection typically involves using anti-BrdU antibodies in an immunohistochemistry or immunofluorescence assay, allowing visualization under a microscope.
